NCT03734575View on ClinicalTrials.gov

ClariCore System Used in Transperineal Prostate Biopsy

NASuspendedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

July 9, 2019

Study Completion Date

July 9, 2019

Conditions
Prostate Cancer
Interventions
DEVICE

ClariCore System

The user will perform a standard trans-perineal biopsy and collect a number of biopsy cores as per standard practice.

Trial Locations (2)

10016

NYU Langone Urology Associates, New York

21287

The James Buchanan Brady Urological Institute and Department of Urology, Baltimore

Sponsors
All Listed Sponsors
lead

Precision Biopsy, Inc.

INDUSTRY

NCT03734575 - ClariCore System Used in Transperineal Prostate Biopsy | Biotech Hunter | Biotech Hunter